Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Concert Health delivers evidence-based behavioral health treatment integrated into primary care using the Collaborative Care Model. The company has cared for over 70,000 patients across at least 19 states with strong outcomes—over half of patients are covered by Medicare or Medicaid. Their approach improves access to mental healthcare and supports primary care providers with psychiatric consultants and masters-level clinicians. Outcomes include significant improvement rates at 90 days and high remission rates for depression/anxiety.
Example results:
- ~52% improvement rate at 90 days (PHQ9/GAD7)
- ~50% remission rate (<5 on PHQ9/GAD7)
The model has been adopted by major partners including Mass General Brigham, AdventHealth, CommonSpirit Health, Mercy Health, Trinity.
Research efforts focus on optimizing collaborative care for co-morbidities and diverse demographics.
Funding includes $42M Series B led by Define Ventures in April 2022; total raised ~$58M.
Operations are expanding nationwide as value-based payment models drive demand for integrated behavioral/primary care.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Concert Health.